Skip to main content
Caplight Logo









MB Therapeutics

MB Therapeutics

Private
MontpellierHealthcare & Life Scienceshttps://mb-therapeutics.com/en/home

Momentum

Top 25%

of companies Caplight tracks

Company Overview

MB Therapeutics operates in Healthcare & Life Sciences and is based in Montpellier. It was founded in 2023.

MB Therapeutics is a biotechnology company developing a solution for manufacturing personalized medicine through 3D printing for healthcare professionals.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, 3D Printing, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

MB Therapeutics Comparables

Compare MB Therapeutics with similar companies based on industry and business-model similarity.

MB Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Doser
88%
FabRx
88%
CurifyLabs
87%
Book a demo to see all comparables

For institutional investors. Book with your work email.

MB Therapeutics Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for MB Therapeutics. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Stéphane Roulon

CEO & Co-founder - Production Of Personalized Medications Through 3D Printing

Founding Team

Ian Soulairol

Chief Technology Officer

Executive Team

Damien STEFANELLI

Chief Operating Officer

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 57% MoM.

  • Jul 20, 2026

    Open roles increased to 3, 2.4x the trailing average.

Book a demo to see all signals

For institutional investors. Book with your work email.

MB Therapeutics Filings

Explore SEC and related filing metadata, where available.

MB Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about MB Therapeutics's valuation, stock price, and market status.

Is MB Therapeutics a public or private company?

MB Therapeutics is a private company.

What is the current stock price of MB Therapeutics?

MB Therapeutics is a private company, so its shares have no public market price. Caplight tracks MB Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MB Therapeutics worth (valuation)?

Valuation information for MB Therapeutics is not publicly available.

Can I buy MB Therapeutics stock?

MB Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MB Therapeutics's last funding round?

Funding round information for MB Therapeutics is not publicly available.

Who are the main investors in MB Therapeutics?

Investor information for MB Therapeutics is not publicly disclosed.

Will MB Therapeutics IPO soon?

No public IPO plans have been announced for MB Therapeutics.

How can I track MB Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades in MB Therapeutics's shares on secondary markets.

Firmographic Details

HeadquartersMontpellier
Employee Range13
Year Founded2023
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?